View in EDS

Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead‐in phase of a randomised controlled trial.

Saved in:
Bibliographic Details
Title: Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead‐in phase of a randomised controlled trial.
Authors: Boulton, Kelsie A. (AUTHOR), Thapa, Rinku (AUTHOR), Song, Yun Ju (AUTHOR), Whitehouse, Andrew J.O. (AUTHOR), DeMayo, Marilena M. (AUTHOR), Gregory, Simon G. (AUTHOR), Pokorski, Izabella (AUTHOR), Granich, Joanna (AUTHOR), Ambarchi, Zahava (AUTHOR), Wray, John (AUTHOR), Thomas, Emma E. (AUTHOR), Hickie, Ian B. (AUTHOR), Guastella, Adam J. (AUTHOR)
Source: Journal of Child Psychology & Psychiatry. Jul2026, Vol. 67 Issue 7, p1085-1094. 10p.
Subjects: Oxytocin, Pearson correlation (Statistics), Intranasal administration, Placebos, Secondary analysis, T-test (Statistics), Autism, Questionnaires, Treatment effectiveness, Severity of illness index, Descriptive statistics, Chi-squared test, Burden of care, Social skills, Asperger's syndrome, Data analysis software, Cognition, Evaluation, Children
Geographic Terms: Australia
Abstract: Background: The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single‐blind, placebo lead‐in phase of a randomised controlled trial (RCT) to investigate the placebo response and its relationship to treatment response in autistic children. Methods: Eighty‐seven autistic children aged 3–12 years (M = 7.27; SD = 2.69; 85.1% male) were consecutively recruited into a multi‐site RCT evaluating the efficacy of oxytocin for improving social responsiveness. Participants underwent a 3‐week, single‐blind placebo lead‐in before randomisation into a 12‐week double‐blind treatment phase (oxytocin, n = 45; placebo, n = 42). The Social Responsiveness Scale, 2nd Edition (SRS‐2) Total Raw Score was used to measure change from baseline to post‐placebo lead‐in. A ≥10‐point improvement defined placebo responders. Results: Nearly half the sample (n = 42, 48.3%) were identified as placebo responders during the lead‐in phase, showing a clinically significant degree of change on the SRS‐2. Caregiver treatment guess did not significantly impact the placebo response (p =.534). Placebo response was associated with greater symptom severity (r's > −.23; p‐values <.037) and higher cognitive ability (r = −.35, p =.004). Smaller placebo responses during the lead‐in phase were associated with larger responses during active treatment in participants receiving oxytocin (r = −.36, p =.017). Placebo responses during the lead‐in phase were observed across all caregiver‐reported measures (Cohen's d =.19–.65). Conclusions: This study provides important information about placebo effects and placebo lead‐in designs for clinical trials in the autism field. We show widespread clinically significant improvement during placebo lead‐in, utility of identifying placebo responders for informing clinical trial analyses, similarities in symptom measure effect sizes for placebo effects, and a lack of influence of caregiver beliefs on placebo responses. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Child Psychology & Psychiatry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 194548825
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead‐in phase of a randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Boulton%2C+Kelsie+A%2E%22&quot;&gt;Boulton, Kelsie A.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Thapa%2C+Rinku%22&quot;&gt;Thapa, Rinku&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Song%2C+Yun+Ju%22&quot;&gt;Song, Yun Ju&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Whitehouse%2C+Andrew+J%2EO%2E%22&quot;&gt;Whitehouse, Andrew J.O.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22DeMayo%2C+Marilena+M%2E%22&quot;&gt;DeMayo, Marilena M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gregory%2C+Simon+G%2E%22&quot;&gt;Gregory, Simon G.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pokorski%2C+Izabella%22&quot;&gt;Pokorski, Izabella&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Granich%2C+Joanna%22&quot;&gt;Granich, Joanna&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ambarchi%2C+Zahava%22&quot;&gt;Ambarchi, Zahava&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Wray%2C+John%22&quot;&gt;Wray, John&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Thomas%2C+Emma+E%2E%22&quot;&gt;Thomas, Emma E.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hickie%2C+Ian+B%2E%22&quot;&gt;Hickie, Ian B.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Guastella%2C+Adam+J%2E%22&quot;&gt;Guastella, Adam J.&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Journal+of+Child+Psychology+%26+Psychiatry%22&quot;&gt;Journal of Child Psychology &amp; Psychiatry&lt;/searchLink&gt;. Jul2026, Vol. 67 Issue 7, p1085-1094. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Oxytocin%22&quot;&gt;Oxytocin&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Pearson+correlation+%28Statistics%29%22&quot;&gt;Pearson correlation (Statistics)&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Intranasal+administration%22&quot;&gt;Intranasal administration&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Placebos%22&quot;&gt;Placebos&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Secondary+analysis%22&quot;&gt;Secondary analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22T-test+%28Statistics%29%22&quot;&gt;T-test (Statistics)&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Autism%22&quot;&gt;Autism&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Questionnaires%22&quot;&gt;Questionnaires&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Treatment+effectiveness%22&quot;&gt;Treatment effectiveness&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Severity+of+illness+index%22&quot;&gt;Severity of illness index&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Descriptive+statistics%22&quot;&gt;Descriptive statistics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Chi-squared+test%22&quot;&gt;Chi-squared test&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Burden+of+care%22&quot;&gt;Burden of care&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Social+skills%22&quot;&gt;Social skills&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Asperger&#39;s+syndrome%22&quot;&gt;Asperger&#39;s syndrome&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Data+analysis+software%22&quot;&gt;Data analysis software&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cognition%22&quot;&gt;Cognition&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Evaluation%22&quot;&gt;Evaluation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Children%22&quot;&gt;Children&lt;/searchLink&gt;
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Australia%22&quot;&gt;Australia&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single‐blind, placebo lead‐in phase of a randomised controlled trial (RCT) to investigate the placebo response and its relationship to treatment response in autistic children. Methods: Eighty‐seven autistic children aged 3–12 years (M = 7.27; SD = 2.69; 85.1% male) were consecutively recruited into a multi‐site RCT evaluating the efficacy of oxytocin for improving social responsiveness. Participants underwent a 3‐week, single‐blind placebo lead‐in before randomisation into a 12‐week double‐blind treatment phase (oxytocin, n = 45; placebo, n = 42). The Social Responsiveness Scale, 2nd Edition (SRS‐2) Total Raw Score was used to measure change from baseline to post‐placebo lead‐in. A ≥10‐point improvement defined placebo responders. Results: Nearly half the sample (n = 42, 48.3%) were identified as placebo responders during the lead‐in phase, showing a clinically significant degree of change on the SRS‐2. Caregiver treatment guess did not significantly impact the placebo response (p =.534). Placebo response was associated with greater symptom severity (r&#39;s &gt; −.23; p‐values &lt;.037) and higher cognitive ability (r = −.35, p =.004). Smaller placebo responses during the lead‐in phase were associated with larger responses during active treatment in participants receiving oxytocin (r = −.36, p =.017). Placebo responses during the lead‐in phase were observed across all caregiver‐reported measures (Cohen&#39;s d =.19–.65). Conclusions: This study provides important information about placebo effects and placebo lead‐in designs for clinical trials in the autism field. We show widespread clinically significant improvement during placebo lead‐in, utility of identifying placebo responders for informing clinical trial analyses, similarities in symptom measure effect sizes for placebo effects, and a lack of influence of caregiver beliefs on placebo responses. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Journal of Child Psychology &amp; Psychiatry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=194548825
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jcpp.70116
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1085
    Subjects:
      – SubjectFull: Oxytocin
        Type: general
      – SubjectFull: Pearson correlation (Statistics)
        Type: general
      – SubjectFull: Intranasal administration
        Type: general
      – SubjectFull: Placebos
        Type: general
      – SubjectFull: Secondary analysis
        Type: general
      – SubjectFull: T-test (Statistics)
        Type: general
      – SubjectFull: Autism
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Severity of illness index
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Chi-squared test
        Type: general
      – SubjectFull: Burden of care
        Type: general
      – SubjectFull: Social skills
        Type: general
      – SubjectFull: Asperger's syndrome
        Type: general
      – SubjectFull: Data analysis software
        Type: general
      – SubjectFull: Cognition
        Type: general
      – SubjectFull: Evaluation
        Type: general
      – SubjectFull: Children
        Type: general
      – SubjectFull: Australia
        Type: general
    Titles:
      – TitleFull: Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead‐in phase of a randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boulton, Kelsie A.
      – PersonEntity:
          Name:
            NameFull: Thapa, Rinku
      – PersonEntity:
          Name:
            NameFull: Song, Yun Ju
      – PersonEntity:
          Name:
            NameFull: Whitehouse, Andrew J.O.
      – PersonEntity:
          Name:
            NameFull: DeMayo, Marilena M.
      – PersonEntity:
          Name:
            NameFull: Gregory, Simon G.
      – PersonEntity:
          Name:
            NameFull: Pokorski, Izabella
      – PersonEntity:
          Name:
            NameFull: Granich, Joanna
      – PersonEntity:
          Name:
            NameFull: Ambarchi, Zahava
      – PersonEntity:
          Name:
            NameFull: Wray, John
      – PersonEntity:
          Name:
            NameFull: Thomas, Emma E.
      – PersonEntity:
          Name:
            NameFull: Hickie, Ian B.
      – PersonEntity:
          Name:
            NameFull: Guastella, Adam J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 00219630
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of Child Psychology & Psychiatry
              Type: main
ResultId 1